These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 5287830)
1. Germine mono- and diacetate in myasthenia gravis. Flacke WE; Blume RP; Scott WR; Foldes FF; Osserman KE Ann N Y Acad Sci; 1971 Sep; 183():316-33. PubMed ID: 5287830 [No Abstract] [Full Text] [Related]
2. [Application of germine alkaloid in myasthenia gravis. 2. Clinical application of germine monoacetate]. Fukushima K; Toyama H Nihon Rinsho; 1973 Feb; 31(2):336-40. PubMed ID: 4737115 [No Abstract] [Full Text] [Related]
3. Treatment of myasthenia gravis with germine diacetate. Flacke W; Caviness VS; Samaha FG N Engl J Med; 1966 Dec; 275(22):1207-14. PubMed ID: 5921854 [No Abstract] [Full Text] [Related]
4. The neuromuscular pharmacology of germine-3-acetate and germine-3,16-diacetate. Standaert FG; Detwiler PB J Pharmacol Exp Ther; 1970 Feb; 171(2):223-41. PubMed ID: 5459059 [No Abstract] [Full Text] [Related]
5. Effect of germine acetates on neuromuscular transmission. Brennan JL; Jones SF; McLeod JG J Neurol Sci; 1971 Jul; 13(3):321-31. PubMed ID: 4330354 [No Abstract] [Full Text] [Related]
6. The effect of germine diacetate on neuro-muscular transmission. Jones SF; Brennan J; McLeon JG Proc Aust Assoc Neurol; 1970; 7():61-5. PubMed ID: 5514826 [No Abstract] [Full Text] [Related]
7. [Application of germine alkaloid in myasthenia gravis. 1. Chemical changes from germine diacetate to germine monoacetate]. Fukushima K; Yoshizawa I Nihon Rinsho; 1973 Feb; 31(2):332-5. PubMed ID: 4737114 [No Abstract] [Full Text] [Related]
8. Sites of action of gerine diacetate in myasthenia gravis. Flacke W; Caviness VS; Samaha F; Schwab RS Trans Am Neurol Assoc; 1967; 92():158-62. PubMed ID: 5634017 [No Abstract] [Full Text] [Related]
9. Formation of germine 3,15-diacetate via the isomerization of germine 3,16-diacetate. Cohen EM; Aczel R; Torchiana M J Med Chem; 1974 Jul; 17(7):769-70. PubMed ID: 4836412 [No Abstract] [Full Text] [Related]
11. Veratrum alkaloids in the therapy of myasthenia gravis. Can Med Assoc J; 1967 Jun; 96(23):1534-5. PubMed ID: 6026341 [No Abstract] [Full Text] [Related]
12. Newer drugs for myasthenia gravis; a microphysiologic study of effects. Hofmann WW J Pharmacol Exp Ther; 1968 Apr; 160(2):349-59. PubMed ID: 5647303 [No Abstract] [Full Text] [Related]
13. Some cardiovascular effects of germine-3-monoacetate. Scriabine A; Stavorski JM; Ludden CT; Stone CA Eur J Pharmacol; 1971 May; 14(4):313-8. PubMed ID: 5157763 [No Abstract] [Full Text] [Related]
14. Treatment of myasthenia gravis. Flacke W N Engl J Med; 1973 Jan; 288(1):27-31. PubMed ID: 4347296 [No Abstract] [Full Text] [Related]
15. [Discussion on "pharmacological studies of germine monoacetate"]. Satoyoshi E Shinkei Kenkyu No Shimpo; 1971; 15(4):917. PubMed ID: 5168645 [No Abstract] [Full Text] [Related]
16. The effects of germine diacetate on the rat phrenic nerve--diaphragm preparation. Foldes FF; Brodman EB; Kranzler HN; Underwood PS; Hemsworth BA Anesthesiology; 1969 Dec; 31(6):522-31. PubMed ID: 5348819 [No Abstract] [Full Text] [Related]
17. Studies on veratrum alkaloids. XLII. The action of some esters of protoverine with acetic acid on mammalian skeletal muscle. Gujral PK; Flacke W J Pharmacol Exp Ther; 1968 Jan; 159(1):153-62. PubMed ID: 5643943 [No Abstract] [Full Text] [Related]
18. Some effects of germine-3-monoacetate (GMA) on isolated rat and guinea-pig ileum. Goldman WJ; Scriabine A J Pharmacol Exp Ther; 1971 Apr; 177(1):181-7. PubMed ID: 5566762 [No Abstract] [Full Text] [Related]
19. [Pharmacological studies of germine 3 monoacetate (GMA)]. Fukushima K Shinkei Kenkyu No Shimpo; 1971; 15(4):914-6. PubMed ID: 5168644 [No Abstract] [Full Text] [Related]
20. Antagonism of neuromuscular blocks by germine monoacetate. Higashi H; Yonemura K; Shimoji K Anesthesiology; 1973 Feb; 38(2):145-52. PubMed ID: 4265216 [No Abstract] [Full Text] [Related] [Next] [New Search]